{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:20:13Z","timestamp":1790259613178,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Virtual Liver Network of the German Federal Ministry of Education and Research","award":["031 6154"],"award-info":[{"award-number":["031 6154"]}]},{"name":"German Federal Ministry of Education and Research","award":["01DR14013"],"award-info":[{"award-number":["01DR14013"]}]},{"name":"Korean Ministry of Science, ICT and Future Planning","award":["NRF-2016M3A9C4953144"],"award-info":[{"award-number":["NRF-2016M3A9C4953144"]}]},{"name":"Korean Ministry of Science, ICT and Future Planning","award":["NRF-2014M3A7B6020163"],"award-info":[{"award-number":["NRF-2014M3A7B6020163"]}]},{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many drugs have the potential to cause drug-induced liver injury (DILI); however, underlying mechanisms are diverse. The concept of adverse outcome pathways (AOPs) has become instrumental for risk assessment of drug class effects. We report AOPs specific for immune-mediated and drug hypersensitivity\/allergic hepatitis by considering genomic, histo- and clinical pathology data of mice and dogs treated with diclofenac. The findings are relevant for other NSAIDs and drugs undergoing iminoquinone and quinone reactive metabolite formation. We define reactive metabolites catalyzed by CYP monooxygenase and myeloperoxidases of neutrophils and Kupffer cells as well as acyl glucuronides produced by uridine diphosphoglucuronosyl transferase as molecular initiating events (MIE). The reactive metabolites bind to proteins and act as neo-antigen and involve antigen-presenting cells to elicit B- and T-cell responses. Given the diverse immune systems between mice and dogs, six different key events (KEs) at the cellular and up to four KEs at the organ level are defined with mechanistic plausibility for the onset and progression of liver inflammation. With mice, cellular stress response, interferon gamma-, adipocytokine- and chemokine signaling provided a rationale for the AOP of immune-mediated hepatitis. With dogs, an erroneous programming of the innate and adaptive immune response resulted in mast cell activation; their infiltration into liver parenchyma and the shift to M2-polarized Kupffer cells signify allergic hepatitis and the occurrence of granulomas of the liver. Taken together, diclofenac induces divergent immune responses among two important preclinical animal species, and the injury pattern seen among clinical cases confirms the relevance of the developed AOP for immune-mediated hepatitis.<\/jats:p>","DOI":"10.1007\/s00204-020-02767-6","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T18:02:53Z","timestamp":1588701773000},"page":"2733-2748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac"],"prefix":"10.1007","volume":"94","author":[{"given":"Saravanakumar","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwa","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-9519","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Borlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"2767_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","volume":"115","author":"DH Adams","year":"2010","unstructured":"Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H (2010) Mechanisms of immune-mediated liver injury. Toxicol Sci 115:307\u2013321. https:\/\/doi.org\/10.1093\/toxsci\/kfq009","journal-title":"Toxicol Sci"},{"key":"2767_CR2","doi-asserted-by":"publisher","first-page":"258164","DOI":"10.1155\/2013\/258164","volume":"2013","author":"Y Aiba","year":"2013","unstructured":"Aiba Y, Nakamura M (2013) The role of TL1A and DR3 in autoimmune and inflammatory diseases. Mediat Inflamm 2013:258164. https:\/\/doi.org\/10.1155\/2013\/258164","journal-title":"Mediat Inflamm"},{"key":"2767_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrrheum.2010.214","volume":"7","author":"GP Aithal","year":"2011","unstructured":"Aithal GP (2011) Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol 7:139\u2013150. https:\/\/doi.org\/10.1038\/nrrheum.2010.214","journal-title":"Nat Rev Rheumatol"},{"key":"2767_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5312\/wjo.v3.i9.142","volume":"3","author":"T Akiyama","year":"2012","unstructured":"Akiyama T, Shinzawa M, Akiyama N (2012) RANKL-RANK interaction in immune regulatory systems. World J Orthop 3:142\u2013150. https:\/\/doi.org\/10.5312\/wjo.v3.i9.142","journal-title":"World J Orthop"},{"key":"2767_CR5","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1021\/tx500345j","volume":"27","author":"TE Allen","year":"2014","unstructured":"Allen TE, Goodman JM, Gutsell S, Russell PJ (2014) Defining molecular initiating events in the adverse outcome pathway framework for risk assessment. Chem Res Toxicol 27:2100\u20132112. https:\/\/doi.org\/10.1021\/tx500345j","journal-title":"Chem Res Toxicol"},{"key":"2767_CR6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/etc.34","volume":"29","author":"GT Ankley","year":"2010","unstructured":"Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730\u2013741. https:\/\/doi.org\/10.1002\/etc.34","journal-title":"Environ Toxicol Chem"},{"key":"2767_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.1840220320","volume":"22","author":"AT Banks","year":"1995","unstructured":"Banks AT, Zimmerman HJ, Ishak KG, Harter JG (1995) Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 22:820\u2013827","journal-title":"Hepatology"},{"key":"2767_CR8","doi-asserted-by":"publisher","first-page":"841362","DOI":"10.1155\/2012\/841362","volume":"2012","author":"S Basseri","year":"2012","unstructured":"Basseri S, Austin RC (2012) Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential. Biochem Res Int 2012:841362. https:\/\/doi.org\/10.1155\/2012\/841362","journal-title":"Biochem Res Int"},{"key":"2767_CR9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1053\/j.gastro.2006.03.022","volume":"130","author":"B Begue","year":"2006","unstructured":"Begue B, Wajant H, Bambou JC, Dubuquoy L, Siegmund D, Beaulieu JF, Canioni D, Berrebi D, Brousse N, Desreumaux P, Schmitz J, Lentze MJ, Goulet O, Cerf-Bensussan N, Ruemmele FM (2006) Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 130:1962\u20131974","journal-title":"Gastroenterology"},{"key":"2767_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1210\/rp.59.1.305","volume":"59","author":"C Bjorbaek","year":"2004","unstructured":"Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305\u2013331","journal-title":"Recent Prog Horm Res"},{"key":"2767_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0041-008X(03)00368-5","volume":"192","author":"UA Boelsterli","year":"2003","unstructured":"Boelsterli UA (2003) Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol 192:307\u2013322","journal-title":"Toxicol Appl Pharmacol"},{"key":"2767_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.taap.2006.12.013","volume":"220","author":"UA Boelsterli","year":"2007","unstructured":"Boelsterli UA, Lim PL (2007) Mitochondrial abnormalities\u2014a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol 220:92\u2013107","journal-title":"Toxicol Appl Pharmacol"},{"key":"2767_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0006-2952(99)00167-7","volume":"58","author":"R Bort","year":"1999","unstructured":"Bort R, Mace K, Boobis A, Gomez-Lechon MJ, Pfeifer A, Castell J (1999) Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol 58:787\u2013796","journal-title":"Biochem Pharmacol"},{"key":"2767_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","volume":"63","author":"M Chen","year":"2015","unstructured":"Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI (2015) Drug-induced liver injury: interactions between drug properties and host factors. J Hepatol 63:503\u2013514. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.016","journal-title":"J Hepatol"},{"key":"2767_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-24716-3_1","volume":"209","author":"EC Cottrell","year":"2012","unstructured":"Cottrell EC, Mercer JG (2012) Leptin receptors. Handb Exp Pharmacol 209:3\u201321. https:\/\/doi.org\/10.1007\/978-3-642-24716-3_1","journal-title":"Handb Exp Pharmacol"},{"key":"2767_CR16","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1021\/tx500514z","volume":"28","author":"M Darnell","year":"2015","unstructured":"Darnell M, Breitholtz K, Isin EM, Jurva U, Weidolf L (2015) Significantly different covalent binding of oxidative metabolites, acyl glucuronides, and S-Acyl CoA conjugates formed from xenobiotic carboxylic acids in human liver microsomes. Chem Res Toxicol 28:886\u2013896. https:\/\/doi.org\/10.1021\/tx500514z","journal-title":"Chem Res Toxicol"},{"key":"2767_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/pr.109.001727","volume":"61","author":"X Deng","year":"2009","unstructured":"Deng X, Luyendyk JP, Ganey PE, Roth RA (2009) Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol Rev 61:262\u2013282. https:\/\/doi.org\/10.1124\/pr.109.001727","journal-title":"Pharmacol Rev"},{"key":"2767_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1172\/JCI10994","volume":"107","author":"LA Denson","year":"2001","unstructured":"Denson LA, Menon RK, Shaufl A, Bajwa HS, Williams CR, Karpen SJ (2001) TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Investig 107:1451\u20131458. https:\/\/doi.org\/10.1172\/JCI10994","journal-title":"J Clin Investig"},{"key":"2767_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1472-765X.2008.02391.x","volume":"47","author":"NK Dutta","year":"2008","unstructured":"Dutta NK, Mazumdar K, Seok SH, Park JH (2008) The anti-inflammatory drug Diclofenac retains anti-listerial activity in vivo. Lett Appl Microbiol 47:106\u2013111. https:\/\/doi.org\/10.1111\/j.1472-765X.2008.02391.x","journal-title":"Lett Appl Microbiol"},{"key":"2767_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.68.4.437","volume":"68","author":"G Fantuzzi","year":"2000","unstructured":"Fantuzzi G, Faggioni R (2000) Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 68:437\u2013446","journal-title":"J Leukoc Biol"},{"key":"2767_CR21","doi-asserted-by":"publisher","first-page":"e00211","DOI":"10.1002\/prp2.211","volume":"4","author":"F Foufelle","year":"2016","unstructured":"Foufelle F, Fromenty B (2016) Role of endoplasmic reticulum stress in drug-induced toxicity. Pharmacol Res Perspect 4:e00211. https:\/\/doi.org\/10.1002\/prp2.211","journal-title":"Pharmacol Res Perspect"},{"key":"2767_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1874091X01105010045","volume":"5","author":"S Franceschelli","year":"2011","unstructured":"Franceschelli S, Moltedo O, Amodio G, Tajana G, Remondelli P (2011) In the Huh7 hepatoma cells diclofenac and indomethacin activate differently the unfolded protein response and induce ER stress apoptosis. Open Biochem J 5:45\u201351. https:\/\/doi.org\/10.2174\/1874091X01105010045","journal-title":"Open Biochem J"},{"key":"2767_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/toxsci\/kfu072","volume":"140","author":"L Fredriksson","year":"2014","unstructured":"Fredriksson L, Wink S, Herpers B, Benedetti G, Hadi M, de Bont H, Groothuis G, Luijten M, Danen E, de Graauw M, Meerman J, van de Water B (2014) Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFalpha-mediated hepatotoxicity. Toxicol Sci 140:144\u2013159. https:\/\/doi.org\/10.1093\/toxsci\/kfu072","journal-title":"Toxicol Sci"},{"key":"2767_CR24","first-page":"529","volume":"255","author":"E Freneaux","year":"1990","unstructured":"Freneaux E, Fromenty B, Berson A, Labbe G, Degott C, Letteron P, Larrey D, Pessayre D (1990) Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids. J Pharmacol Exp Ther 255:529\u2013535","journal-title":"J Pharmacol Exp Ther"},{"key":"2767_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.dmpk.2017.10.002","volume":"33","author":"R Fujiwara","year":"2018","unstructured":"Fujiwara R, Yoda E, Tukey RH (2018) Species differences in drug glucuronidation: humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans. Drug Metab Pharmacokinet 33:9\u201316","journal-title":"Drug Metab Pharmacokinet"},{"key":"2767_CR26","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","volume":"26","author":"TJ Gan","year":"2010","unstructured":"Gan TJ (2010) Diclofenac: an update on its mechanism of action and safety profile. Curr Med Res Opin 26:1715\u20131731. https:\/\/doi.org\/10.1185\/03007995.2010.486301","journal-title":"Curr Med Res Opin"},{"key":"2767_CR27","doi-asserted-by":"publisher","first-page":"536962","DOI":"10.1155\/2015\/536962","volume":"2015","author":"R Ghosh","year":"2015","unstructured":"Ghosh R, Alajbegovic A, Gomes AV (2015) NSAIDs and cardiovascular diseases: role of reactive oxygen species. Oxid Med Cell Longev 2015:536962. https:\/\/doi.org\/10.1155\/2015\/536962","journal-title":"Oxid Med Cell Longev"},{"key":"2767_CR28","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.bcp.2003.08.003","volume":"66","author":"MJ Gomez-Lechon","year":"2003","unstructured":"Gomez-Lechon MJ, Ponsoda X, O'Connor E, Donato T, Castell JV, Jover R (2003a) Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem Pharmacol 66:2155\u20132167","journal-title":"Biochem Pharmacol"},{"key":"2767_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0887-2333(03)00105-X","volume":"17","author":"MJ Gomez-Lechon","year":"2003","unstructured":"Gomez-Lechon MJ, Ponsoda X, O'Connor E, Donato T, Jover R, Castell JV (2003b) Diclofenac induces apoptosis in hepatocytes. Toxicol In Vitro 17:675\u2013680","journal-title":"Toxicol In Vitro"},{"key":"2767_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/carcin\/bgs317","volume":"34","author":"JP Guegan","year":"2013","unstructured":"Guegan JP, Ezan F, Theret N, Langouet S, Baffet G (2013) MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. Carcinogenesis 34:38\u201347. https:\/\/doi.org\/10.1093\/carcin\/bgs317","journal-title":"Carcinogenesis"},{"key":"2767_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/CEG.S43737","volume":"7","author":"L Hammerich","year":"2014","unstructured":"Hammerich L, Tacke F (2014) Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol 7:297\u2013306. https:\/\/doi.org\/10.2147\/CEG.S43737","journal-title":"Clin Exp Gastroenterol"},{"key":"2767_CR32","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1001\/jama.1990.03450200068033","volume":"264","author":"SM Helfgott","year":"1990","unstructured":"Helfgott SM, Sandberg-Cook J, Zakim D, Nestler J (1990) Diclofenac-associated hepatotoxicity. JAMA 264:2660\u20132662","journal-title":"JAMA"},{"key":"2767_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/acs.chemrestox.6b00385","volume":"30","author":"TB Hughes","year":"2017","unstructured":"Hughes TB, Swamidass SJ (2017) Deep learning to predict the formation of quinone species in drug metabolism. Chem Res Toxicol 30:642\u2013656. https:\/\/doi.org\/10.1021\/acs.chemrestox.6b00385","journal-title":"Chem Res Toxicol"},{"key":"2767_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0168-8278(90)90077-5","volume":"10","author":"TJ Iveson","year":"1990","unstructured":"Iveson TJ, Ryley NG, Kelly PM, Trowell JM, McGee JO, Chapman RW (1990) Diclofenac associated hepatitis. J Hepatol 10:85\u201389","journal-title":"J Hepatol"},{"key":"2767_CR35","doi-asserted-by":"publisher","first-page":"e0165638","DOI":"10.1371\/journal.pone.0165638","volume":"11","author":"SW Kang","year":"2016","unstructured":"Kang SW, Haydar G, Taniane C, Farrell G, Arias IM, Lippincott-Schwartz J, Fu D (2016) AMPK activation prevents and reverses drug-induced mitochondrial and hepatocyte injury by promoting mitochondrial fusion and function. PLoS One 11:e0165638. https:\/\/doi.org\/10.1371\/journal.pone.0165638","journal-title":"PLoS One"},{"key":"2767_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1189\/jlb.0909602","volume":"88","author":"N Karin","year":"2010","unstructured":"Karin N (2010) The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J Leukoc Biol 88:463\u2013473. https:\/\/doi.org\/10.1189\/jlb.0909602","journal-title":"J Leukoc Biol"},{"key":"2767_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2460\/ajvr.2000.61.802","volume":"61","author":"P Kay-Mugford","year":"2000","unstructured":"Kay-Mugford P, Benn SJ, LaMarre J, Conlon P (2000) In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs. Am J Vet Res 61:802\u2013810. https:\/\/doi.org\/10.2460\/ajvr.2000.61.802","journal-title":"Am J Vet Res"},{"key":"2767_CR38","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/etc.4125","volume":"37","author":"D Knapen","year":"2018","unstructured":"Knapen D, Angrish MM, Fortin MC, Katsiadaki I, Leonard M, Margiotta-Casaluci L, Munn S, O'Brien JM, Pollesch N, Smith LC, Zhang X, Villeneuve DL (2018) Adverse outcome pathway networks I: development and applications. Environ Toxicol Chem 37:1723\u20131733. https:\/\/doi.org\/10.1002\/etc.4125","journal-title":"Environ Toxicol Chem"},{"key":"2767_CR39","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.3748\/wjg.v12.i46.7413","volume":"12","author":"G Kolios","year":"2006","unstructured":"Kolios G, Valatas V, Kouroumalis E (2006) Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 12:7413\u20137420","journal-title":"World J Gastroenterol"},{"key":"2767_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/00024382-200210000-00014","volume":"18","author":"F Kong","year":"2002","unstructured":"Kong F, Guo X, Noel JG, Wells DA, Lovell GJ, Ogle CK (2002) Thermal injury-induced increases of hepatocyte SOCS3 lead to decreases in STAT3. Shock 18:374\u2013379","journal-title":"Shock"},{"key":"2767_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/taap.1993.1097","volume":"120","author":"A Kretz-Rommel","year":"1993","unstructured":"Kretz-Rommel A, Boelsterli UA (1993) Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol Appl Pharmacol 120:155\u2013161","journal-title":"Toxicol Appl Pharmacol"},{"key":"2767_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1152\/physrev.00028.2011","volume":"92","author":"JM Kyriakis","year":"2012","unstructured":"Kyriakis JM, Avruch J (2012) Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92:689\u2013737. https:\/\/doi.org\/10.1152\/physrev.00028.2011","journal-title":"Physiol Rev"},{"key":"2767_CR43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1124\/mol.109.062364","volume":"77","author":"JS Lagas","year":"2010","unstructured":"Lagas JS, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH (2010) Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters. Mol Pharmacol 77:687\u2013694. https:\/\/doi.org\/10.1124\/mol.109.062364","journal-title":"Mol Pharmacol"},{"key":"2767_CR44","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ajg.2008.149","volume":"104","author":"L Laine","year":"2009","unstructured":"Laine L, Goldkind L, Curtis SP, Connors LG, Yanqiong Z, Cannon CP (2009) How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol 104:356\u2013362. https:\/\/doi.org\/10.1038\/ajg.2008.149","journal-title":"Am J Gastroenterol"},{"key":"2767_CR45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7698","author":"EH Lee","year":"2016","unstructured":"Lee EH, Oh JH, Selvaraj S, Park SM, Choi MS, Spanel R, Yoon S, Borlak J (2016) Immunogenomics reveal molecular circuits of diclofenac induced liver injury in mice. Oncotarget. https:\/\/doi.org\/10.18632\/oncotarget.7698","journal-title":"Oncotarget"},{"key":"2767_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1471-4914(03)00071-6","volume":"9","author":"K Ley","year":"2003","unstructured":"Ley K (2003) The role of selectins in inflammation and disease. Trends Mol Med 9:263\u2013268","journal-title":"Trends Mol Med"},{"key":"2767_CR47","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/sj.bjp.0707358","volume":"152","author":"E Malle","year":"2007","unstructured":"Malle E, Furtmuller PG, Sattler W, Obinger C (2007) Myeloperoxidase: a target for new drug development? Br J Pharmacol 152:838\u2013854","journal-title":"Br J Pharmacol"},{"key":"2767_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1053\/jhep.2002.31871","volume":"35","author":"Y Masubuchi","year":"2002","unstructured":"Masubuchi Y, Nakayama S, Horie T (2002) Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology 35:544\u2013551","journal-title":"Hepatology"},{"key":"2767_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-9255-8-22","volume":"8","author":"AM Miller","year":"2011","unstructured":"Miller AM (2011) Role of IL-33 in inflammation and disease. J Inflamm (Lond) 8:22. https:\/\/doi.org\/10.1186\/1476-9255-8-22","journal-title":"J Inflamm (Lond)"},{"key":"2767_CR50","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H (2017) Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab 28:388\u2013397","journal-title":"Trends Endocrinol Metab"},{"key":"2767_CR51","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S1567-5769(03)00131-0","volume":"3","author":"H Muhl","year":"2003","unstructured":"Muhl H, Pfeilschifter J (2003) Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 3:1247\u20131255","journal-title":"Int Immunopharmacol"},{"key":"2767_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.toxlet.2006.10.014","volume":"168","author":"DJ Naisbitt","year":"2007","unstructured":"Naisbitt DJ, Sanderson LS, Meng X, Stachulski AV, Clarke SE, Park BK (2007) Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett 168:45\u201350","journal-title":"Toxicol Lett"},{"key":"2767_CR53","doi-asserted-by":"publisher","first-page":"172894","DOI":"10.1155\/2012\/172894","volume":"2012","author":"H Nakagawa","year":"2012","unstructured":"Nakagawa H, Maeda S (2012) Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Patholog Res Int 2012:172894. https:\/\/doi.org\/10.1155\/2012\/172894","journal-title":"Patholog Res Int"},{"key":"2767_CR54","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1158\/1078-0432.CCR-12-1961","volume":"19","author":"K Nikolaou","year":"2013","unstructured":"Nikolaou K, Sarris M, Talianidis I (2013) Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer. Clin Cancer Res 19:2810\u20132816. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1961","journal-title":"Clin Cancer Res"},{"key":"2767_CR55","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.3390\/ijms15046990","volume":"15","author":"DB Njoku","year":"2014","unstructured":"Njoku DB (2014) Drug-induced hepatotoxicity: metabolic, genetic and immunological basis. Int J Mol Sci 15:6990\u20137003. https:\/\/doi.org\/10.3390\/ijms15046990","journal-title":"Int J Mol Sci"},{"key":"2767_CR56","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/jat.3388","volume":"37","author":"S Oda","year":"2017","unstructured":"Oda S, Shirai Y, Akai S, Nakajima A, Tsuneyama K, Yokoi T (2017) Toxicological role of an acyl glucuronide metabolite in diclofenac-induced acute liver injury in mice. J Appl Toxicol 37:545\u2013553. https:\/\/doi.org\/10.1002\/jat.3388","journal-title":"J Appl Toxicol"},{"issue":"533\u201346","key":"2767_CR57","doi-asserted-by":"publisher","first-page":"vii","DOI":"10.1016\/j.cld.2013.07.012","volume":"17","author":"V Patel","year":"2013","unstructured":"Patel V, Sanyal AJ (2013) Drug-induced steatohepatitis. Clin Liver Dis 17(533\u201346):vii. https:\/\/doi.org\/10.1016\/j.cld.2013.07.012","journal-title":"Clin Liver Dis"},{"key":"2767_CR58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1590\/S0004-27302012000900001","volume":"56","author":"G Paz-Filho","year":"2012","unstructured":"Paz-Filho G, Mastronardi C, Franco CB, Wang KB, Wong ML, Licinio J (2012) Leptin: molecular mechanisms, systemic pro-inflammatory effects, and clinical implications. Arq Bras Endocrinol Metabol 56:597\u2013607","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"Suppl 1","key":"2767_CR59","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","volume":"22","author":"D Pessayre","year":"2007","unstructured":"Pessayre D (2007) Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22(Suppl 1):S20\u2013S27","journal-title":"J Gastroenterol Hepatol"},{"key":"2767_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/toxsci\/kfz006","volume":"168","author":"NL Pollesch","year":"2019","unstructured":"Pollesch NL, Villeneuve DL, O'Brien JM (2019) Extracting and benchmarking emerging adverse outcome pathway knowledge. Toxicol Sci 168:349\u2013364. https:\/\/doi.org\/10.1093\/toxsci\/kfz006","journal-title":"Toxicol Sci"},{"key":"2767_CR61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1517\/17425255.2012.648613","volume":"8","author":"KR Przybylak","year":"2012","unstructured":"Przybylak KR, Cronin MT (2012) In silico models for drug-induced liver injury\u2014current status. Expert Opin Drug Metab Toxicol 8:201\u2013217. https:\/\/doi.org\/10.1517\/17425255.2012.648613","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2767_CR62","doi-asserted-by":"publisher","first-page":"e67976","DOI":"10.1371\/journal.pone.0067976","volume":"8","author":"B Pulli","year":"2013","unstructured":"Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, Linnoila JJ, Chen JW (2013) Measuring myeloperoxidase activity in biological samples. PLoS One 8:e67976. https:\/\/doi.org\/10.1371\/journal.pone.0067976","journal-title":"PLoS One"},{"key":"2767_CR63","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gut.32.11.1381","volume":"32","author":"P Purcell","year":"1991","unstructured":"Purcell P, Henry D, Melville G (1991) Diclofenac hepatitis. Gut 32:1381\u20131385. https:\/\/doi.org\/10.1136\/gut.32.11.1381","journal-title":"Gut"},{"key":"2767_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0192623308329474","volume":"37","author":"ZA Radi","year":"2009","unstructured":"Radi ZA (2009) Pathophysiology of cyclooxygenase inhibition in animal models. Toxicol Pathol 37:34\u201346. https:\/\/doi.org\/10.1177\/0192623308329474","journal-title":"Toxicol Pathol"},{"key":"2767_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.etp.2006.06.004","volume":"58","author":"ZA Radi","year":"2006","unstructured":"Radi ZA, Khan NK (2006) Effects of cyclooxygenase inhibition on the gastrointestinal tract. Exp Toxicol Pathol 58:163\u2013173","journal-title":"Exp Toxicol Pathol"},{"key":"2767_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.2008.058248","volume":"62","author":"R Ramachandran","year":"2009","unstructured":"Ramachandran R, Kakar S (2009) Histological patterns in drug-induced liver disease. J Clin Pathol 62:481\u2013492. https:\/\/doi.org\/10.1136\/jcp.2008.058248","journal-title":"J Clin Pathol"},{"key":"2767_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tox.2013.08.002","volume":"312","author":"S Ramm","year":"2013","unstructured":"Ramm S, Mally A (2013) Role of drug-independent stress factors in liver injury associated with diclofenac intake. Toxicology 312:83\u201396. https:\/\/doi.org\/10.1016\/j.tox.2013.08.002","journal-title":"Toxicology"},{"key":"2767_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.tox.2015.03.004","volume":"331","author":"S Ramm","year":"2015","unstructured":"Ramm S, Morissey B, Hernandez B, Rooney C, Pennington SR, Mally A (2015) Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS\/diclofenac co-administration. Toxicology 331:100\u2013111. https:\/\/doi.org\/10.1016\/j.tox.2015.03.004","journal-title":"Toxicology"},{"key":"2767_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/toxsci\/kfl173","volume":"96","author":"RA Roberts","year":"2007","unstructured":"Roberts RA, Ganey PE, Ju C, Kamendulis LM, Rusyn I, Klaunig JE (2007) Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96:2\u201315","journal-title":"Toxicol Sci"},{"key":"2767_CR70","doi-asserted-by":"publisher","first-page":"e114085","DOI":"10.1371\/journal.pone.0114085","volume":"9","author":"N Sahini","year":"2014","unstructured":"Sahini N, Selvaraj S, Borlak J (2014) Whole genome transcript profiling of drug induced steatosis in rats reveals a gene signature predictive of outcome. PLoS One 9:e114085. https:\/\/doi.org\/10.1371\/journal.pone.0114085","journal-title":"PLoS One"},{"key":"2767_CR71","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fphys.2012.00213","volume":"3","author":"Y Saiman","year":"2012","unstructured":"Saiman Y, Friedman SL (2012) The role of chemokines in acute liver injury. Front Physiol 3:213. https:\/\/doi.org\/10.3389\/fphys.2012.00213","journal-title":"Front Physiol"},{"key":"2767_CR72","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/hep.24756","volume":"55","author":"N Sakai","year":"2012","unstructured":"Sakai N, Van Sweringen HL, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ, Lentsch AB (2012) Receptor activator of nuclear factor-kappaB ligand (RANKL) protects against hepatic ischemia\/reperfusion injury in mice. Hepatology 55:888\u2013897. https:\/\/doi.org\/10.1002\/hep.24756","journal-title":"Hepatology"},{"key":"2767_CR73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0168-8278(90)90127-D","volume":"11","author":"R Sallie","year":"1990","unstructured":"Sallie R (1990) Diclofenac hepatitis. J Hepatol 11:281","journal-title":"J Hepatol"},{"key":"2767_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2131\/jts.43.75","volume":"43","author":"E Sasaki","year":"2018","unstructured":"Sasaki E, Yokoi T (2018) Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries. J Toxicol Sci 43:75\u201387. https:\/\/doi.org\/10.2131\/jts.43.75","journal-title":"J Toxicol Sci"},{"key":"2767_CR75","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.immuni.2009.01.007","volume":"30","author":"Y Sawa","year":"2009","unstructured":"Sawa Y, Arima Y, Ogura H, Kitabayashi C, Jiang JJ, Fukushima T, Kamimura D, Hirano T, Murakami M (2009) Hepatic interleukin-7 expression regulates T cell responses. Immunity 30:447\u2013457. https:\/\/doi.org\/10.1016\/j.immuni.2009.01.007","journal-title":"Immunity"},{"key":"2767_CR76","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/ibd.21325","volume":"16","author":"M Scharl","year":"2010","unstructured":"Scharl M, Hruz P, McCole DF (2010) Protein tyrosine phosphatase non-receptor type 2 regulates IFN-gamma-induced cytokine signaling in THP-1 monocytes. Inflamm Bowel Dis 16:2055\u20132064. https:\/\/doi.org\/10.1002\/ibd.21325","journal-title":"Inflamm Bowel Dis"},{"key":"2767_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13032","author":"PA Schmeltzer","year":"2015","unstructured":"Schmeltzer PA, Kosinski AS, Kleiner DE, Hoofnagle JH, Stolz A, Fontana RJ, Russo MW, Drug-Induced Liver Injury Network (DILIN) (2015) Liver injury from nonsteroidal anti-inflammatory drugs in the United States. Liver Int. https:\/\/doi.org\/10.1111\/liv.13032","journal-title":"Liver Int"},{"key":"2767_CR78","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1124\/dmd.114.061705","volume":"43","author":"RJ Scialis","year":"2015","unstructured":"Scialis RJ, Csanaky IL, Goedken MJ, Manautou JE (2015) Multidrug resistance-associated protein 3 plays an important role in protection against acute toxicity of diclofenac. Drug Metab Dispos 43:944\u2013950. https:\/\/doi.org\/10.1124\/dmd.114.061705","journal-title":"Drug Metab Dispos"},{"key":"2767_CR79","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/S0016-5085(98)70026-5","volume":"115","author":"S Seitz","year":"1998","unstructured":"Seitz S, Boelsterli UA (1998) Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 115:1476\u20131482","journal-title":"Gastroenterology"},{"key":"2767_CR80","doi-asserted-by":"publisher","first-page":"107763","DOI":"10.18632\/oncotarget.21201","volume":"8","author":"S Selvaraj","year":"2017","unstructured":"Selvaraj S, Oh JH, Spanel R, Langer F, Han HY, Lee EH, Yoon S, Borlak J (2017) The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury. Oncotarget 8:107763\u2013107824. https:\/\/doi.org\/10.18632\/oncotarget.21201","journal-title":"Oncotarget"},{"key":"2767_CR81","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1124\/dmd.118.080515","volume":"46","author":"DA Smith","year":"2018","unstructured":"Smith DA, Hammond T, Baillie TA (2018) Safety assessment of Acyl glucuronides-A simplified paradigm. Drug Metab Dispos 46:908\u2013912. https:\/\/doi.org\/10.1124\/dmd.118.080515","journal-title":"Drug Metab Dispos"},{"key":"2767_CR82","doi-asserted-by":"publisher","first-page":"5253623","DOI":"10.1155\/2018\/5253623","volume":"2018","author":"P Sriuttha","year":"2018","unstructured":"Sriuttha P, Sirichanchuen B, Permsuwan U (2018) Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials. Int J Hepatol 2018:5253623. https:\/\/doi.org\/10.1155\/2018\/5253623","journal-title":"Int J Hepatol"},{"key":"2767_CR83","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1021\/tx200168d","volume":"24","author":"AF Stepan","year":"2011","unstructured":"Stepan AF, Walker DP, Bauman J, Price DA, Baillie TA, Kalgutkar AS, Aleo MD (2011) Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol 24:1345\u20131410. https:\/\/doi.org\/10.1021\/tx200168d","journal-title":"Chem Res Toxicol"},{"key":"2767_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.tiv.2015.11.020","volume":"31","author":"M Syed","year":"2016","unstructured":"Syed M, Skonberg C, Hansen SH (2016) Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI). Toxicol In Vitro 31:93\u2013102. https:\/\/doi.org\/10.1016\/j.tiv.2015.11.020","journal-title":"Toxicol In Vitro"},{"key":"2767_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071447","author":"Y Takahashi","year":"2017","unstructured":"Takahashi Y (2017) The role of growth hormone and insulin-like growth factor-I in the liver. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18071447","journal-title":"Int J Mol Sci"},{"key":"2767_CR86","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1254\/jjp.64.71","volume":"64","author":"F Takayama","year":"1994","unstructured":"Takayama F, Egashira T, Yamanaka Y (1994) Effect of diclofenac, a non-steroidal anti-inflammatory drug, on lipid peroxidation caused by ischemia\u2013reperfusion in rat liver. Jpn J Pharmacol 64:71\u201378","journal-title":"Jpn J Pharmacol"},{"key":"2767_CR87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/1389200033489398","volume":"4","author":"W Tang","year":"2003","unstructured":"Tang W (2003) The metabolism of diclofenac\u2013enzymology and toxicology perspectives. Curr Drug Metab 4:319\u2013329","journal-title":"Curr Drug Metab"},{"key":"2767_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","volume":"1822","author":"TC Theoharides","year":"2012","unstructured":"Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochim Biophys Acta 1822:21\u201333. https:\/\/doi.org\/10.1016\/j.bbadis.2010.12.014","journal-title":"Biochim Biophys Acta"},{"key":"2767_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2017.03.003","volume":"272","author":"TR Van Vleet","year":"2017","unstructured":"Van Vleet TR, Liu H, Lee A, Blomme EAG (2017) Acyl glucuronide metabolites: implications for drug safety assessment. Toxicol Lett 272:1\u20137","journal-title":"Toxicol Lett"},{"key":"2767_CR90","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","volume":"312","author":"M Vinken","year":"2013","unstructured":"Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158\u2013165. https:\/\/doi.org\/10.1016\/j.tox.2013.08.011","journal-title":"Toxicology"},{"key":"2767_CR91","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/acs.chemrestox.5b00208","volume":"28","author":"M Vinken","year":"2015","unstructured":"Vinken M (2015) Adverse outcome pathways and drug-induced liver injury testing. Chem Res Toxicol 28:1391\u20131397. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00208","journal-title":"Chem Res Toxicol"},{"key":"2767_CR92","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1007\/s00204-017-2020-z","volume":"91","author":"M Vinken","year":"2017","unstructured":"Vinken M, Knapen D, Vergauwen L, Hengstler JG, Angrish M, Whelan M (2017) Adverse outcome pathways: a concise introduction for toxicologists. Arch Toxicol 91:3697\u20133707. https:\/\/doi.org\/10.1007\/s00204-017-2020-z","journal-title":"Arch Toxicol"},{"key":"2767_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1044-5323(02)00123-9","volume":"15","author":"MM Wong","year":"2003","unstructured":"Wong MM, Fish EN (2003) Chemokines: attractive mediators of the immune response. Semin Immunol 15:5\u201314","journal-title":"Semin Immunol"},{"key":"2767_CR94","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tox.2012.01.008","volume":"293","author":"A Yano","year":"2012","unstructured":"Yano A, Higuchi S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T (2012) Involvement of immune-related factors in diclofenac-induced acute liver injury in mice. Toxicology 293:107\u2013114. https:\/\/doi.org\/10.1016\/j.tox.2012.01.008","journal-title":"Toxicology"},{"key":"2767_CR95","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12307-012-0117-8","volume":"5","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Li LY (2012) TNFSF15 modulates neovascularization and inflammation. Cancer Microenviron 5:237\u2013247. https:\/\/doi.org\/10.1007\/s12307-012-0117-8","journal-title":"Cancer Microenviron"},{"key":"2767_CR96","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000479878","volume":"101","author":"B Zhang","year":"2018","unstructured":"Zhang B, Li Q, Shi C, Zhang X (2018) Drug-induced pseudoallergy: a review of the causes and mechanisms. Pharmacology 101:104\u2013110. https:\/\/doi.org\/10.1159\/000479878","journal-title":"Pharmacology"},{"key":"2767_CR97","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1124\/jpet.112.198077","volume":"343","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Zhang QY (2012) Role of intestinal cytochrome p450 enzymes in diclofenac-induced toxicity in the small intestine. J Pharmacol Exp Ther 343:362\u2013370. https:\/\/doi.org\/10.1124\/jpet.112.198077","journal-title":"J Pharmacol Exp Ther"},{"key":"2767_CR98","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/biof.107","volume":"36","author":"NW Zwirner","year":"2010","unstructured":"Zwirner NW, Domaica CI (2010) Cytokine regulation of natural killer cell effector functions. BioFactors 36:274\u2013288. https:\/\/doi.org\/10.1002\/biof.107","journal-title":"BioFactors"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02767-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-020-02767-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02767-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T03:54:46Z","timestamp":1666497286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-020-02767-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2767"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02767-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"20 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}